Page last updated: 2024-12-08
ipalbidine
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Description
ipalbidine: photoalkaloid isolated from seeds of Ipomoea hardwickii Hemsl.; structure given in first source; RR from Chemical Abstracts Index Guide; RN given refers to (+-)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Related Flora
| Flora | Rank | Flora Definition | Family | Family Definition |
|---|---|---|---|---|
| Ipomoea | genus | A plant genus in the family CONVOLVULACEAE best known for morning glories (a common name also used with CONVOLVULUS) and sweet potato.[MeSH] | Convolvulaceae | The morning glory family of flowering plants, of the order Solanales, which includes about 50 genera and at least 1,400 species. Leaves are alternate and flowers are funnel-shaped. Most are twining and erect herbs, with a few woody vines, trees, and shrubs.[MeSH] |
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 161520 |
| SCHEMBL ID | 3133193 |
| MeSH ID | M0160850 |
Synonyms (6)
| Synonym |
|---|
| ipalbidine |
| 4-(7-methyl-1,2,3,5,8,8a-hexahydroindolizin-6-yl)phenol |
| phenol, 4-(1,2,3,5,8,8a-hexahydro-7-methyl-6-indolizinyl)-, (+-)- |
| 26294-41-7 |
| SCHEMBL3133193 |
| DTXSID50949157 |
Research Excerpts
Overview
Ipalbidine (Ipa) is a photoactive alkaloid isolated from the seeds of ipomoea hardwickki Hemsl.
| Excerpt | Reference | Relevance |
|---|---|---|
| "Ipalbidine (Ipa) is a photoactive alkaloid isolated from the seeds of ipomoea hardwickki Hemsl. " | ( [Effect of norepinephrinergic system on ipalbidine analgesia]. Chu, YH; Wang, LM, 1996) | 2 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (20.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 4 (80.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||